Antibiotic Indications For Resistant Pathogens Could Rely On PK/PD – FDA
Executive Summary
Companies seeking an indication for an antimicrobial agent to treat resistant pathogens could rely mostly on pharmacokinetic and pharmacodynamic studies, FDA said